•
DT
DTIL
Precision BioSciences, Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
96.53M
Volume
202.45K
52W High
$8.82
52W Low
$3.75
Open
$0.00
Prev Close
$4.17
Day Range
0.00 - 0.00
About Precision BioSciences, Inc. Common Stock
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Latest News
Genome Editing Market Forecast to Reach $23.6 Billion by 2031 Registering 16.6% CAGR: Insights Into Technology and Investment Trends
GlobeNewswire Inc.•Just now
CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
GlobeNewswire Inc.•Mar 5
Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82%
GlobeNewswire Inc.•Sep 10
Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%
GlobeNewswire Inc.•Sep 10
Does Precision BioSciences (DTIL) Have the Potential to Rally 200.55% as Wall Street Analysts Expect?
Zacks Investment Research•May 29
Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings)
Benzinga•May 16
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 9
Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
Zacks Investment Research•Apr 17